A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine

A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine

Rahul Bhambri,1 Jack Mardekian,1 Larry Z Liu,1,2 Edward Schweizer,3 Elodie Ramos1 1Pfizer, Inc., 2Weill Medical College of Cornell University, New York, NY, USA; 3Paladin Consulting Group, Princeton, NJ, USAAbstract: Migraine is a commonly occurring, chronic disorder that can cause significant disa...

Full description

Bibliographic Details
Main Authors: Bhambri R, Mardekian J, Liu LZ, Schweizer E, Ramos E
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:International Journal of General Medicine
Online Access:http://www.dovepress.com/a-review-of-the-pharmacoeconomics-of-eletriptan-for-the-acute-treatmen-peer-reviewed-article-IJGM

Internet

http://www.dovepress.com/a-review-of-the-pharmacoeconomics-of-eletriptan-for-the-acute-treatmen-peer-reviewed-article-IJGM

Similar Items